Back | Next |
home / stock / tlsa / tlsa message board
Subject | By | Source | When |
---|---|---|---|
$TLSA The trading | The Night Stalker | investorshub | 09/22/2023 5:05:39 PM |
Price trading | Anita Dump | investorshub | 09/22/2023 4:33:15 PM |
$TLSA short squeeze | Lanceroni | investorshub | 09/22/2023 3:27:40 PM |
$TLSA bears are running | Lanceroni | investorshub | 09/22/2023 2:45:49 PM |
MomentumIts gaining up | Anita Dump | investorshub | 09/22/2023 1:40:19 PM |
$TLSA Thoughts on where this is headed? | ElvisCobain | investorshub | 09/22/2023 12:46:32 PM |
$TLSA Long and strong lets hope im right | Count Crypto | investorshub | 09/22/2023 11:48:26 AM |
$TLSA Price now | Steve200747909 | investorshub | 09/22/2023 11:28:44 AM |
$TLSA good read | mfayman | investorshub | 09/22/2023 10:41:02 AM |
$TLSA Price now last up | Count Crypto | investorshub | 09/22/2023 9:50:17 AM |
$TLSA The now | Steve200747909 | investorshub | 09/22/2023 9:39:07 AM |
Price gaining | Crusader | investorshub | 09/22/2023 7:44:11 AM |
$TLSA Looks pretty positive | EOT | investorshub | 09/22/2023 6:26:35 AM |
$TLSA MomentumIts gaining last trade up | elmasry | investorshub | 09/22/2023 4:19:14 AM |
$TLSA we got news | doolz | investorshub | 09/22/2023 12:24:09 AM |
Time for this to show some returns | Crusader | investorshub | 09/21/2023 9:23:36 PM |
$TLSA great news | nickwill69 | investorshub | 09/21/2023 7:49:48 PM |
short squeeze all day | Steve200747909 | investorshub | 09/21/2023 7:14:49 PM |
$TLSA short squeeze article | Crusader | investorshub | 09/21/2023 6:12:51 PM |
$TLSA short squeeze signal | The Night Stalker | investorshub | 09/21/2023 2:18:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.88%Change Percent:
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ant...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...